Surgical Information Sciences (SIS) has announced the commencement of its post-market VISION study evaluating visualisation of the subthalamic nucleus (STN) and globus pallidus internus (GPi) for deep brain stimulation (DBS) surgery in patients with Parkinson’s disease.
This study aims to evaluate the potential of the company’s technology in enhancing the accuracy of DBS implant placement for Parkinson’s patients. It will involve the participation of 90 patients across multiple sites, and represents “a significant step in the pursuit of improved treatment for those living with this challenging condition”, as per an SIS press release.
DBS has shown promise in managing parkinsonian symptoms, but its success is “closely tied” to the precision of implant placement within the STN and GPi. SIS believes that its cutting-edge visualisation technology has the potential to significantly improve the accuracy of this procedure, ultimately leading to improved patient outcomes, the release adds.
“The VISION study presents an opportunity to assist surgeons and programming physicians in treating patients with Parkinson’s disease,” said Patrick Senatus (Hartford Hospital, Hartford, USA). “By enhancing visualisation, the accuracy of DBS implant placement may be improved through further customising targeting of therapeutic brain regions. I am enthusiastic about the possibilities that this research holds.”
“Today marks a momentous occasion for SIS. We are proud to take the first step toward demonstrating improved outcomes of DBS surgery through patient-specific visualisation of target structures and lead placement,” added SIS president and chief executive officer Brad Swatfager. “Our team has worked hard to develop this cutting-edge technology, and we look forward to collaborating with healthcare professionals across the country to explore its full potential, and improve the experience for physicians and patients.”
